US Stock MarketDetailed Quotes

RAPT RAPT Therapeutics

Watchlist
  • 1.200
  • +0.010+0.84%
Close Feb 14 16:00 ET
  • 1.200
  • 0.000-0.01%
Post 20:01 ET
158.41MMarket Cap-0.43P/E (TTM)

RAPT Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RAPT Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

RAPT Therapeutics Earnings Reports

  • RAPT Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 12:04 ET

  • RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Third Quarter 2024 Financial Results

    Nov 12, 2024 09:36 ET

  • RAPT Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 08:14 ET

  • RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 8, 2024 08:09 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +17.56%
    DexCom
    DXCM
    +5.92%
    Hutchmed (China)
    HCM
    +4.39%
    New Fortress Energy
    NFE
    +2.70%
    Enerpac Tool
    EPAC
    +1.85%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 13, 2025

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data